| Next 10 |
Ad
NCNA Articles NuCana plc
home / stock / ncna / ncna articles
Articles | NuCana plc (NASDAQ:NCNA)
-
NEW YORK, May 30, 2024 (GLOBE NEWSWIRE) -- NuCana plc (NASDAQ:NCNA) announced today that Hugh Griffith, Chief Executive Officer, and Don Munoz, ...
-
EDINBURGH, United Kingdom, May 21, 2024 (GLOBE NEWSWIRE) -- NuCana plc (NASDAQ:NCNA) announced today that Hugh Griffith, Chief Executive Officer...
-
NUC-7738 Reprograms Cancer Cell Lipid Metabolism to Make Tumors Less Aggressive and Promote Cancer Cell Death NUC-7738 Alters Ribosome Biogenesis ...
-
NuCana plc (NASDAQ:NCNA) shares are trading lower by 15.2% to $0.26 during Thursday’s session after the company late Wednesday said it intend...
-
Shares of RH (NYSE: RH) rose sharply in today’s pre-market trading following the release of quarterly results. RH posted weaker-than-expecte...
-
U.S. stocks traded mixed toward the end of trading, with the Dow Jones gaining over 100 points on Wednesday. The Dow traded up 0.28% to 39,113.63 w...
-
Shares of Clover Health Investments, Corp. (NASDAQ: CLOV) rose sharply during Wednesday’s session after the company reported better-than-exp...
-
NuCana Plc (NASDAQ:NCNA) shares are trading higher Wednesday after the company was granted a U.S. Patent for phosphoramidate derivatives for use in...
-
U.S. stocks traded mixed midway through trading, with the Dow Jones gaining around 150 points on Wednesday. The Dow traded up 0.42% to 39,170.63 wh...
Stock Information
Get NCNA Alerts
News, Short Squeeze, Breakout and More Instantly...
Ad
-
A look at the top 10 most actives in the United States Nu Holdings Ltd. Class A (NU) rose 5.2% to $14.97 on volume of 557,476,210 shares UTime Limited (WTO) fell 16.6% to $0.0756 on volume of 370,923,634 shares NVIDIA Corporation (NVDA) rose 1.5% to $119.37 on volume of 331,427,665 shares ...
-
2024-08-29 19:30:04 ET William Blair analyst issues MARKET PERFORM recommendation for NCNA on August 29, 2024 06:32PM ET. NCNA was trading at $7.73 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analyst recommendations are : 1 - Buy ...
-
NuTide:323 Study to be Discontinued Following Pre-Planned Initial Analysis and Recommendation from the Steering Committee NuTide:701 and NuTide:303 Studies Continue Unchanged with Encouraging Data on NUC-7738 plus Pembrolizumab to be Presented at the ESMO Annual Conference in Septem...
Important Investor News Alert (OTC: AABB)
-
LAS VEGAS, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Asia Broadband Inc. (OTC: AABB) (“AABB” or the “Company”) is pleased to announce that the Company has been thrilled with the rise in gold and silver prices this year and the corresponding increases to AABB’s quarterly...